Skip to main content

Platypnea–Orthodeoxia Syndrome (POS)

 

What is Platypnea–Orthodeoxia Syndrome (POS)
Platypnea–Orthodeoxia Syndrome (POS): Causes, Mechanisms, Diagnosis, and Management

Platypnea–orthodeoxia syndrome is a rare but important clinical condition characterized by positional dyspnea and arterial desaturation. Recognition is crucial because many cases are treatable once the underlying mechanism is identified.


Definition


Platypnea refers to worsening dyspnea in the upright position that improves when lying supine.

Orthodeoxia refers to a fall in arterial oxygen saturation or PaO₂ on assuming an upright posture, with improvement in the supine position.


Platypnea–orthodeoxia syndrome is defined by the coexistence of both features.


Pathophysiology


The hallmark of POS is position-dependent right-to-left shunting or severe ventilation–perfusion (V/Q) mismatch. When the patient stands or sits upright, anatomical or functional changes increase shunting or worsen perfusion of poorly ventilated lung zones, leading to hypoxemia. When supine, these abnormalities partially resolve.


Major Causes of Platypnea–Orthodeoxia Syndrome


1. Intracardiac Shunts




These are the most commonly described causes of POS.


• Patent foramen ovale (PFO)

• Atrial septal defect (ASD)

• Atrial septal aneurysm with fenestration


PFO is the most frequent association. However, a PFO alone is usually insufficient to cause POS. An additional anatomical or functional factor is typically required to redirect venous blood flow across the interatrial septum in the upright position.


Conditions that Promote Interatrial Septal Distortion


• Post lung transplantation

• Post-pneumonectomy

• Ascending aortic dilatation or aneurysm

• Kyphoscoliosis

• Right hemidiaphragm paralysis


These conditions alter cardiac geometry, especially in the upright posture, facilitating right-to-left shunting through a PFO or ASD even in the absence of pulmonary hypertension.


2. Pulmonary Causes (V/Q Mismatch or Intrapulmonary Shunt)




• Interstitial lung disease

• Pulmonary arteriovenous malformations

• Hepatopulmonary syndrome


In these disorders, upright posture increases perfusion to poorly ventilated or abnormally dilated vascular segments, worsening hypoxemia.


Hepatopulmonary Syndrome and POS


Hepatopulmonary syndrome is a classic pulmonary cause of POS. Intrapulmonary vascular dilatations are predominantly located in the lung bases, leading to marked orthodeoxia when standing due to gravity-dependent blood flow.


Clinical Presentation


• Dyspnea that worsens on sitting or standing

• Improvement of symptoms on lying flat

• Unexplained hypoxemia resistant to supplemental oxygen (especially in shunt physiology)

• Cyanosis in advanced cases


A careful history focusing on positional symptoms is essential, as routine evaluation may miss the diagnosis.


Diagnostic Evaluation


1. Pulse Oximetry and Arterial Blood Gases

Demonstrate a significant drop in oxygen saturation or PaO₂ when upright compared with supine.



2. Transthoracic Echocardiography

Initial screening to assess chamber size, septal abnormalities, and cardiac anatomy.



3. Contrast (Bubble) Echocardiography

Key diagnostic test. Agitated saline injected intravenously demonstrates right-to-left shunt. Performing the study in both supine and upright or semi-upright positions increases diagnostic yield.



4. Transesophageal Echocardiography

Provides detailed assessment of interatrial septum, PFO, ASD, and associated anatomical distortions.



5. CT Pulmonary Angiography or Contrast CT Chest

Useful for detecting pulmonary AV malformations or post-surgical anatomical changes.



6. Lung Perfusion Scans

Can help identify intrapulmonary shunting.




Management


Treatment depends on the underlying cause.


Intracardiac Shunts


• Percutaneous closure of PFO or ASD is highly effective

• Results in rapid and often complete resolution of symptoms and hypoxemia


Pulmonary Causes


• Pulmonary AV malformations: transcatheter embolization

• Hepatopulmonary syndrome: supportive oxygen therapy and liver transplantation in eligible patients

• Interstitial lung disease: disease-specific management


Supportive Care


• Supplemental oxygen

• Avoidance of prolonged upright posture until definitive treatment


Prognosis


The prognosis of platypnea–orthodeoxia syndrome is excellent when the underlying cause is identified and treated appropriately, particularly in cases due to intracardiac shunts. Delayed diagnosis can lead to prolonged morbidity and unnecessary investigations.


Key Takeaways


• Platypnea–orthodeoxia syndrome is a positional cause of dyspnea and hypoxemia

• PFO is the most common associated condition but usually requires an additional anatomical trigger

• Positional oxygen desaturation is the clinical clue

• Contrast echocardiography is central to diagnosis

• Many cases are curable with targeted intervention


For more cardiology infographics and educational content, visit:

drmusmanjaved.com


Comments

Popular posts from this blog

Brugada ECG vs Incomplete Right Bundle Branch Block (iRBBB)

Brugada ECG vs Incomplete Right Bundle Branch Block (iRBBB) Why this differentiation matters Brugada pattern is a malignant channelopathy associated with sudden cardiac death, while incomplete RBBB is usually a benign conduction variant. Mislabeling Brugada as iRBBB can be fatal; overcalling iRBBB as Brugada can lead to unnecessary anxiety and ICD implantation. --- 1. Basic Definitions Brugada ECG Pattern Primary repolarization abnormality Genetic sodium-channel disorder Characteristic ST-segment elevation in V1–V3 Risk of ventricular fibrillation and sudden death Incomplete RBBB (iRBBB) Depolarization abnormality Delay in right ventricular conduction Common in healthy individuals Usually asymptomatic and benign --- 2. ECG Morphology: Side-by-Side Comparison QRS Duration Brugada: QRS usually <120 ms iRBBB: QRS <120 ms, but with RBBB morphology --- V1–V2 Pattern (Key Differentiator) Brugada Pseudo-RBBB appearance ST elevation ≥2 mm ST segment is coved or saddleback Terminal QRS bl...

𝘼𝙣𝙩𝙞𝙘𝙤𝙖𝙜𝙪𝙡𝙖𝙩𝙞𝙤𝙣 𝘼𝙛𝙩𝙚𝙧 𝙎𝙩𝙧𝙤𝙠𝙚

 𝘼𝙣𝙩𝙞𝙘𝙤𝙖𝙜𝙪𝙡𝙖𝙩𝙞𝙤𝙣 𝘼𝙛𝙩𝙚𝙧 𝙎𝙩𝙧𝙤𝙠𝙚 in  Patient with AF and acute IS/TIA European Heart Association Guideline recommends: • 1 days after TIA • 3 days after mild stroke • 6 days after moderate stroke • 12 days after severe stroke Early anticoagulation can decrease a risk of recurrent stroke and embolic events but may increase a risk of secondary hemorrhagic transformation of brain infarcts.  The 1-3-6-12-day rule is a known consensus with graded increase in delay of anticoagulation between 1 and 12 days after onset of ischemic stroke or transient ischemic attack(TIA), according to neurological severity based on European expert opinions. However, this rule might be somewhat later than currently used in a real-world practical setting.

Acute Treatment of Hyperkalemia

Acute Treatment of Hyperkalemia – A Practical, Bedside-Oriented Guide Hyperkalemia is a potentially life-threatening electrolyte abnormality that demands prompt recognition and decisive management. The danger lies not only in the absolute potassium value but in its effects on cardiac conduction, which can rapidly progress to fatal arrhythmias. Acute treatment focuses on three parallel goals: stabilizing the cardiac membrane, shifting potassium into cells, and removing excess potassium from the body. Understanding this stepwise approach helps clinicians act quickly and rationally in emergency settings. Why Hyperkalemia Is Dangerous Potassium plays a key role in maintaining the resting membrane potential of cardiac myocytes. Elevated serum potassium reduces the transmembrane gradient, leading to slowed conduction, ECG changes, ventricular arrhythmias, and asystole. Importantly, ECG changes do not always correlate with potassium levels, so treatment decisions should be based on clinical c...